SCHEDULE 13G
Statement of Beneficial Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001831942-25-000033
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X01/primary_doc.xml…